Graphical Abstract
Keywords: Single-atom nanozyme, Neutralization, Peroxidase-like activity, Reactive oxygen species, Anti-SARS-CoV2
Abstract
The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO2 supported single-atom nanozyme containing atomically dispersed Ag atoms (Ag-TiO2 SAN) is designed to serve as a highly efficient antiviral nanomaterial. Compared with traditional nano-TiO2 and Ag, Ag-TiO2 SAN exhibits higher adsorption (99.65%) of SARS-CoV2 pseudovirus. This adsorption ability is due to the interaction between SAN and receptor binding domain (RBD) of spike 1 protein of SARS-CoV2. Theoretical calculation and experimental evidences indicate that the Ag atoms of SAN strongly bind to cysteine and asparagine, which are the most abundant amino acids on the surface of spike 1 RBD. After binding to the virus, the SAN/virus complex is typically phagocytosed by macrophages and colocalized with lysosomes. Interestingly, Ag-TiO2 SAN possesses high peroxidase-like activity responsible for reactive oxygen species production under acid conditions. The highly acidic microenvironment of lysosomes could favor oxygen reduction reaction process to eliminate the virus. With hACE2 transgenic mice, Ag-TiO2 SAN showed efficient anti-SARS-CoV2 pseudovirus activity. In conclusion, Ag-TiO2 SAN is a promising nanomaterial to achieve effective antiviral effects for SARS-CoV2.
Introduction
In December 2019, a new infectious respiratory disease emerged, causing fever, severe respiratory illness, and pneumonia [1], [2]. Various studies showed that it is caused by a new severe acute respiratory syndrome β-coronavirus (SARS-CoV2), and hence the disease was named coronavirus disease 2019 (COVID-19) [3]. COVID-19 is the third large-scale pandemic caused by coronavirus in the last two decades after SARS and Middle East Respiratory Syndrome (MERS) [4], [5]. The number of laboratory-confirmed COVID-19 cases is already more than 90 times higher than the total number of confirmed cases of SARS and MERS [6]. Thus, SARS-CoV2 is posing a serious threat to global public health. There is an urgent need for specific anticoronavirus therapeutics and prophylactics for treatment and prevention.
Nanomaterials possess considerable potential for antimicrobial application [7], [8], [9], [10]. Recently, Bonam et al. summarized the rationale applications of nanomedicine against Coronaviruses [11]. Especially for SARS-CoV2, various nanomaterials have shown promising antiviral activity [12], [13]. Compared to traditional materials, nanomaterials are superior because of their small size, large specific surface area, high adsorption and catalytic capacity [14]. Many nanomaterials have been reported to have a binding preference for amino acids or peptides. For instance, peptides have been reported to interact with the surface of gold nanoparticles (NPs) through cysteine residues or attach to the surface by a combination of several non-cysteine amino acids (i.e., tyrosine, serine, lysine, aspartic acid) via multidentate binding [15]. Sarikaya et al. used a set of experimentally determined quartz binding peptides with different affinities to quartz (10 strong, 14 moderate, and 15 weak peptide binders to quartz) [16]. Of note, Yacaman et al. designed 1–10 nm Ag NPs, which specifically interact with sulfur-bearing residues on the gp120 glycoprotein of human immunodeficiency virus 1 (HIV-1) [17], indicating that nanomaterials have advantages in antimicrobial application. Importantly, nanomaterials harboring intrinsic enzyme-like activity have been identified [18], [19], [20], [21]. These characteristics of nanomaterials prompted us to design a novel material that specifically absorbs to SARS-CoV2 and subsequently eliminate the virus. Among various inorganic materials, Ag and TiO2 NPs are considered effective antimicrobial agents. Nano-Ag is one of the promising nanomaterial microbicides due to its effectiveness (even at small doses) and minimal toxicity and side effects [22]. Nano-Ag shows high adsorption to microbes and subsequently produces Ag+ and reactive oxygen species (ROS), which are responsible for microbial shell breakdown [23], [24], [25]. Nano-TiO2 is another biocompatible nanomaterial that can be excited by near-ultraviolet rays and possesses photochemical sterilization and self-cleaning capabilities [26], [27]. The photochemical sterilization effects of nano-TiO2 have been intensively investigated on a wide spectrum of organisms, including virus, bacteria and tumor cells [28], [29], [30]. Although significant progress has been made in nanomaterial research, improving the biocatalytic sites of nanomaterials poses a major challenge due to the inhomogeneity of traditional nanomaterials.
Single-atom nanozymes (SANs), which are defined as mimic enzyme containing only isolated single metal atoms on various substrates with atomically dispersed metal centers, maximize the atomic utilization efficiency and density of active sites [31]. In addition, the homogeneous structure of SANs facilitates the accurate discernment and characterization of active sites, thus providing deep insight into the construction of desirable SANs for high-performance catalysis at the atomic level in the biological milieu [32], [33]. Consequently, the intrinsic physiochemical and catalytic features of SANs make them intriguing candidates for the design of highly efficient biocatalysts and for pioneering new paradigms in promoting beneficial catalytic reactions for desirable biomedical applications. In addition, such atomically dispersed metal catalysts have also found applications in the chemical engineering industry due to their superior catalytic performance compared with corresponding metal nanocatalysts, especially in value-added chemical production, energy transformation and environmental protection [34]. Among these applications, quite a few metal single-atom catalysts have demonstrated intriguing potential for activating O2 molecules, which offers the possibility to catalyze the formation of singlet O2, thus being promising for biomedicines. Our group is devoted to exploring the strategies for synthesizing single-atom catalysts with precise and uniform gram-scale structures, which is key for future applications [35], [36]. Many studies have shown that SANs exhibit very strong antibacterial and antiviral effects [37], [38], [39], which led us to consider SANs as a nanomaterial against SARS-CoV2.
Here, we successfully designed Ag-TiO2 SAN, and demonstrated that the SAN exhibits excellent anti-SARS-CoV2 activity. This novel SAN exhibits enhanced in vitro absorption with a rate of up to 99.65% for SARS-CoV2 pseudovirus, which highly expresses spike protein of SARS-CoV2 on HIV-1 surface. Theoretical calculations and experimental evidences indicate that Ag atoms of SAN strongly bind to cysteine and asparagine, which are the most abundant amino acids on the surface of spike 1 protein. In vivo, the SAN efficiently promotes virus phagocytosis by macrophages. The intrinsic peroxidase-like activity of Ag-TiO2 SAN exerts promising antiviral effects in lysosomes. With viral elimination models, we found that Ag-TiO2 SAN significantly eliminates pseudovirus, which could protect host cells from infection ( Scheme 1). In addition, gram-scale SANs can be produced via an energy- and cost-efficient approach. This study provides new insight for employing anti-SARS-CoV2 nanomaterials.
Results and discussion
Characterization of Ag-TiO2 SAN
One gram of Ag-TiO2 SAN was prepared via a wet chemistry method in one batch, with the loading of Ag determined as 1.0 wt% via inductively coupled plasma optical emission spectrometry (ICP-OES). Anatase TiO2 with a size of 5–10 nm was selected as the support, due to the uniform crystalline structure and surface arrangement, which is beneficial for precisely conducting site-specific studies and mechanistic investigations. TiO2 has a small size advantage over larger ones, resulting in easier passive targeting and larger surface area, which could load more metals or drug molecules. The geometric structure of Ag-TiO2 SAN was characterized ( Fig. 1a). Scanning electron microscopy (SEM) and dynamic light scattering (DLS) experiments were first employed for checking whether the decoration of Ag led to aggregation of TiO2; the results showed that the SAN is uniformly distributed and the size of SAN is 10–15 nm (Fig. 1b-c). As shown in Fig. 1d-e, Ag was atomically dispersed on the TiO2 support in Ag-TiO2 SAN, with Ag, Ti, and O elements well distributed across the space. In comparison, when observing Ag NPs, particles with a size of 3–5 nm were detected (Fig. 1f-g). Further, the Ag-TiO2 interaction was investigated by Raman and solid ultraviolet−visible (UV–vis) spectroscopy (Fig. 1h). The peak around 450 nm was ascribed to Ag species whose size is larger than 3 nm, further confirming the existence of Ag NPs. Fig. 1i manifests that the characteristic peak of TiO2 was maintained before and after Ag doping, but the Eg value increased, which is more prominent in SAN. Furthermore, the UV–vis spectra indicate that the bandgaps of TiO2 decreased obviously in both Ag/TiO2 (Ag-TiO2 SAN) and Ag NPs/TiO2, with Eg values of 2.99 eV and 2.84 eV, respectively. These observations serve as solid and unambiguous evidence for the strong metal-support interaction in these two materials, and different electronic structures offer supported Ag materials good potential for outperforming TiO2 in catalytic reactions.
Ag-TiO2 SAN exhibits high adsorption ability for SARS-CoV2 pseudovirus
In order to evaluate anti-virus effects of Ag-TiO2 SAN, we firstly introduced the pseudovirus, which expresses spike protein of SARS-CoV2 on HIV-1 surface and carries luciferase reporter protein internally. We overexpressed human angiotensin converting enzyme 2 (hACE2) in 293T cells (hACE2OE-293T). The overexpression of hACE2 was confirmed by the mRNA and protein levels (Figure S1a-c). In our in vitro viral infection assay, the ability of pseudovirus to infect hACE2OE-293T was obviously higher than wild type 293T cells (hACE2WT-293T, Figure S2).
To determine the proper concentrations of Ag-TiO2 SAN, nano-TiO2 and nano-Ag for the experiments, we evaluated the viability of cells treated by these nanomaterials in the concentration range from 0 to 300 μg mL−1 for 72 h. The results showed that cell viability was more than 95% when treated with 1 wt% Ag loaded SAN, nano-TiO2, or nano-Ag at a concentration of 50 μg mL−1 (Figure S3a). Cell integrity was not affected at this concentration (Figure S3b). In addition, we evaluated the dissolution of Ag during the storage of 1 wt% Ag loaded SAN. ICP-MS result showed that the silver content in Ag NPs solution (10 mg mL−1) was 11.4 ± 1.25 ng mL−1, while the silver level (1.0 ± 0.46 ng mL−1) in Ag-TiO2 SAN solution (10 mg mL−1) was much lower due to Ag being only 1 wt% of the SAN (Figure S4), indicating the limited toxic of Ag-TiO2 SAN.
Next, we analyzed the adsorption ability of 0.2 wt% and 1 wt% Ag atom loaded SANs for SARS-CoV2 pseudovirus. The result showed that 1 wt% Ag loaded SAN exhibits higher adsorption of pseudovirus compared with 0.2 wt% Ag loaded SAN ( Fig. 2a). Thus, the high adsorption of 1 wt% Ag loaded SAN is due to surficial Ag atoms ratio. We also analyzed the adsorption ability of 1 wt% Ag loaded SAN, nano-TiO2 and nano-Ag for pseudovirus. Surprisingly, 1 wt% Ag loaded SAN exhibits 99.65% adsorption ability for pseudovirus compared with 82.71% for nano-TiO2 and 90.62% for nano-Ag (Fig. 2b-c). Consistently, 50 μg mL−1 Ag-TiO2 SAN (1 wt% Ag) also exhibited promising adsorption ability for spike 1 protein of SARS-CoV2 (Figure S5). Thus, 1 wt% Ag loaded SAN was used for further experiments. Finally, we confirmed the direct interaction between the SAN and pseudovirus by SEM. Interestingly, we observed that the Ag-TiO2 SAN (smaller particles) was absorbed to the pseudovirus (bigger particles) surface (Fig. 2d-e). In the skin test assay, Ag-TiO2 SAN and nano-TiO2 have no influence on mouse skin. However, nano-Ag severely damages the cuticle of mouse skin (Figure S6), suggesting that Ag-TiO2 SAN has a broad application in viral adsorption, such as face mask coating and disinfectant.
Ag-TiO2 SAN interacts with spike protein of SARS-CoV2
Spike protein is the outermost structure on SARS-CoV2, and is responsible for binding to host cells. Furthermore, 1 wt% Ag loaded SAN exhibited better adsorption of pseudovirus compared with 0.2 wt% Ag loaded SAN. Thus, we speculate that this adsorption is partially dependent on the interaction of Ag atoms and spike protein. To test this hypothesis, we incubated RBD of spike 1 protein (S1 RBD, 51 KD) with Ag-TiO2 SAN, nano-TiO2, nano-Ag and a mass ratio as 1:1 mixture of nano-TiO2/Ag, and collected the supernatant for cell immunofluorescence assay. As shown in Fig. 3a-b, Ag-TiO2 SAN exhibited higher adsorption of S1 RBD than nano-TiO2, nano-Ag and the nano-TiO2/Ag mixture. To confirm this result, we measured the S1 RBD levels in precipitates and supernatants of nanomaterial incubated by western blot. The results show that Ag-TiO2 SAN binds to more S1 RBD than nano-TiO2 and nano-Ag (Fig. 3e). The opposite results were detected in the supernatant (Fig. 3f). In addition, we performed immuno-precipitation assay to evaluate the ratio of the SANs that are bound to S1 RBD. The results show that 0.85 ± 0.12 μg SANs bound to 1 μg S1 RBD (Figure S7).
Spike protein of SARS-CoV2, unlike that of other β-B coronaviruses, harbors a special S1/S2 furin-recognizable site, indicating that its spike protein might possess some unique infectious properties. Lu et al. reported that a typical syncytium structure naturally formed by SARS-CoV2 infected cells, which is mediated by spike protein [40]. To investigate whether Ag-TiO2 SAN interferes with spike-mediated cell-cell fusion, we transfected 293 T cells with spike protein-GFP reporter as the effector cells (Figure S8a-c) and used hACE2OE-293T as the target cells. We first sorted GFP positive cells and incubated with Ag-TiO2 SAN, nano-TiO2, nano-Ag, and nano-TiO2/Ag mixture (mass ratio as 1:1). After effector cells and target cells were cocultured at 37 °C for 2 h, the fused cells were at least twice large as normal cells. In the Ag-TiO2 SAN treated group, spike-mediated cell-cell fusion was significantly inhibited compared with the PBS treated group, even though nano-TiO2, nano-Ag, and nano-TiO2/Ag treatment also inhibit cell-cell fusion to different degrees (Fig. 3c-d), indicating that the SAN serves as a blocker for virus entering into host cells. To directly demonstrate the interaction between Ag-TiO2 SAN and S1 RBD of SARS-CoV2, we cocultured S1 RBD (2 μg) and Ag-TiO2 SAN (50 μg mL−1) at room temperature for 1 h. Energy disperse spectroscopy (EDS) analysis showed that the spike-Ag-TiO2 SAN complex was formed (Fig. 3g), suggesting a direct interaction between Ag-TiO2 SAN and spike protein of SARS-CoV2 takes place.
Human angiotensin converting enzyme 2 (hACE2) is considered to be one major receptor of spike protein mediating SARS-CoV2 infection to host cells [41]. However, whether the adsorption by Ag-TiO2 SAN of SARS-CoV2 could interfere with the interaction between S1 RBD and hACE2 remains unclear. To answer this question, we performed pulldown assay in vitro. Interestingly, the ability of S1 RBD binds to hACE2 is significantly inhibited by Ag-TiO2 SAN (Fig. 3h). Furthermore, enzyme linked immunosorbent assay (ELISA) were performed to further evaluate this inhibition. As shown in Figure S9a, the interaction of Ag-TiO2 SAN and S1 RBD is negligibly affected by serum proteins. Importantly, compared with nano-TiO2 and nano-Ag, the SAN exhibited the best blocking effect for binding of S1 RBD and hACE2 (Figure S9b). Together, these data demonstrate that Ag-TiO2 SAN possesses high affinity for S1 RBD of SARS-CoV2, and this adsorption protects host cells from SARS-CoV2 infection.
Peroxidase-like activity and kinetic analysis of Ag-TiO2 SAN
Nanomaterials can catalyze the production of high levels of reactive oxygen species (ROS), depending on intrinsic nanozyme activity, which is another approach to achieve antimicrobial effects[38], [42]. Therefore, we next tested whether Ag-TiO2 SAN possesses peroxidase-like activity, catalyzing the conversion of hydrogen peroxide (H2O2) into hydroxyl radicals. As shown in Fig. 4a and Figure S10a-c, Ag-TiO2 SAN effectively catalyzed the oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB) in the presence of H2O2 in a concentration, pH and temperature-dependent manner. The optimal pH and temperature were approximately 5.0 and 35 °C, respectively, which are similar to those of natural horseradish peroxidase (4.5 and 35 °C). In addition, the optimal pH and temperature of Ag-TiO2 SAN are similar to those of nano-Ag, suggesting the peroxidase-like activity of Ag-TiO2 SAN is mainly dependent on Ag atoms. Of note, 1 wt% Ag-doped Ag-TiO2 SAN exhibited higher peroxidase-like activity than traditional nano-Ag, suggesting the efficient utilization of SAN. To analyze the catalytic activity of Ag-TiO2 SAN, we calculated the Michaelis-Menten constant (K M) (Fig. 4b-c). K M, which represents the affinity of substrates to the enzyme. The K M value was 39.9 mM for H2O2 and 0.032 mM for TMB (Table S1).
To the best of our knowledge, hydroxyl radicals can cause damage to viral components, inactivating the viral proteins and nucleic acids[43], [44], [45]. Therefore, it is important to determine the generation of hydroxyl radicals by Ag-TiO2 SAN. We added H2O2 to the Ag-TiO2 SAN system and measured the amounts of hydroxyl radicals by electron spin resonance (ESR) (Fig. 4d). Based on these results, we determined the ability of Ag-TiO2 SAN to generate hydroxyl radicals. Terephthalic acid (TA) was used to indirectly detect the concentration of hydroxyl radicals. As shown in Fig. 4e, the generation of hydroxyl radicals is increased with time, even though the pH was close to neutral. These results suggest that Ag-TiO2 SAN could steadily induce the generation of hydroxyl radicals by catalyzing the decomposition of H2O2.
Pharmacokinetics and biocompatibility of intravenously injected Ag-TiO2 SAN
The pharmacokinetics of the intravenously injected sequential Ag-TiO2 SAN were assessed to reveal its in vivo behavior. Initially, the time-dependent biodistribution of Ag-TiO2 SAN in the major organs was studied. The results show that Ag-TiO2 SAN is mainly distributed in liver, spleen, and lung tissue because of the capture by the reticuloendothelial and vascular system ( Fig. 5a). In the blood-circulation experiment, a circulating half-life in the bloodstream of 3.76 h was obtained (Fig. 5b).
Toxic side effects for normal organs have been the main problem in the application of nanomaterials. Therefore, we first tested the biocompatibility of Ag-TiO2 SAN. The results show no significant difference in mouse body weight after persistent treatment with PBS (control) and Ag-TiO2 SAN (2–10 mg kg−1) for 24 days (Fig. 5c). Furthermore, the bleeding and clotting times were not affected by 10 mg kg−1 Ag-TiO2 SAN (Fig. 5d-e). To investigate whether Ag-TiO2 SAN inflicts damage to organs, histological examination (HE) staining of various major organs (heart, liver, spleen, lung, and kidney) from mice injected with PBS and Ag-TiO2 SAN was conducted to investigate the biological toxicity (Fig. 5f). No obvious pathological abnormality or inflammation was observed from both groups. Overall, these results firmly show the in vivo biocompatibility of Ag-TiO2 SAN, potentiating its further application as antiviral agent.
Ag-TiO2 SAN eliminates SARS-CoV2 pseudovirus in vivo
Abundant proteins in body fluids/blood such as albumin may affect the in vivo adsorption ability of Ag-TiO2 SAN for virus particles. To exclude these effects, the SAN was treated with human serum/S1 RBD and PBS/S1 RBD mixture, respectively. We found that the SAN remained exhibiting high adsorption of S1 RBD in the presence of serum ( Fig. 6a). Moreover, the interaction between Ag-TiO2 SAN with S1 RBD, or pseudovirus was negligibly affected by serum proteins, even in the case of directly mixing with serum (Figure S11a-b). Furthermore, the peroxidase-like activity was negligibly affected by serum proteins (Figure S12). With antiviral assay in vitro, we found that the residual virus in supernatant of virus/SAN/H2O2 significantly decreased compared with those of only virus and virus/H2O2 groups. Moreover, antiviral activity of Ag-TiO2 SAN was not affected by serum (Figure S13a). Similarly, we cocultured S1 RBD, SAN and H2O2, with or without serum for 1 h at room temperature. The results showed that S1 RBD was significantly degraded regardless of the presence of serum or not (Figure S13b). These results suggest that the anti-viral effect of Ag-TiO2 SAN is negligibly affected by serum proteins.
To better understand the binding characteristics of Ag-TiO2 SAN and S1 RBD, X-ray photoelectron spectroscopy (XPS) was conducted to compare the binding energies of N 1s and S 2p electrons. For N 1s, the peak locations of S1 RBD (Figure S14a) were unchanged after incubation with nano-TiO2 (Figure S14b) and Ag-TiO2 SAN (Figure S14c). Of note, XPS results of S 2p help to characterize the interaction between Ag-TiO2 SAN and S1 RBD. Compared with the XPS of S1 RBD or S1 RBD-TiO2 complex (Figure S14d-e), the electronic state of S changed only with the S1 RBD-SAN complex (Figure S14f). The intrinsically strong coordinating interaction between Ag and S assisted the active targeting of Ag-TiO2 SAN toward the SARS-CoV2 pseudovirus. The interaction between Ag and S is consistent with other reports [46], [47]. To further confirm the specific combination between Ag-TiO2 SAN and S1 RBD, we compared the distribution of superficial amino acids on S1 RBD and serum albumin (67 KD). As shown in Fig. 6b, the percentages of asparagine, glycine, and cysteine are higher on the S1 RBD surface than on the albumin. Subsequently, we investigated the binding conformations of Ag-TiO2 SAN and the side chains of asparagine, glycine, and cysteine, then calculated their binding energies. In this study, the experimental pH was 7.45 (1% PBS), which is higher than the isoelectric points of asparagine (5.41), glycine (5.97), and cysteine (5.02). Thus the −COOH groups are present in their anion forms and the amino acids are charged with one negative charge. The Ag@Ti6O9(OH)6 cluster (Fig. 6c) was used to simulate the NPs with Ag atoms doped on the anatase TiO2, which was also used in former reports [48]. The binding energies between the side chains of asparagine (-CH2C(O)NH2), glycine (-H), and cysteine (-SH) with Ag@Ti6O9(OH)6 are −11.62, −1.43 and −26.60 kcal mol−1, respectively, indicating that Ag atoms have the strongest interaction with cysteine because of the strong Ag-S bond. Furthermore, asparagine has medium binding energy because the N-atom of the amide has a lone pair of electrons, which forms a coordination bond with the Ag atoms. Glycine, with the -H side chain, has weak interactions with Ag atoms (Fig. 6d). These data provide solid evidence for the dominant affinity between Ag-TiO2 SAN and S1 RBD.
SARS-CoV2 infects lung tissues through the respiratory tract, then enters into bloodstream to infect hACE2+ tissues [49]. Thus, we used two models, lung administration and tail injection of the pseudovirus, to evaluate the therapy efficacy of Ag-TiO2 SAN at different stages of SARS-CoV2 infection. hACE2 transgenic mice were used to evaluate the anti-viral activity of Ag-TiO2 SAN in vivo. The gene expression of hACE2 was confirmed with qPCR analysis (Figure S15a). With Cy5.5 labeled S1 RBD and SARS-CoV2 pseudovirus, we detected high levels of S1 RBD and SARS-CoV2 pseudovirus in the lung tissues of hACE2 transgenic mice from 0 to 24 h. In contrast, the infection of S1 RBD and pseudovirus significantly decreased when lung tissues were pretreated with Ag-TiO2 SAN. Importantly, the S1 RBD and pseudovirus are almost completely eliminated after 24 h ( Fig. 7a−d). In addition, the results of tail injection of the pseudovirus showed that Ag-TiO2 SAN is effectively anti-SARS-CoV2 in vivo (Figure S15b-c), indicating that the SAN is effective antiviral activity both in the early and late stage of SARS-CoV2 infection.
To understand the mechanisms underlying the antiviral effects of Ag-TiO2 SAN, we tracked the biological location of SAN in vivo. As known, macrophages are strategically located throughout the body tissues and liquids, where they non-specifically ingest and process foreign materials [50]. During pathogen infection, macrophages kill or degrade microorganisms by producing ROS and reducing the intracellular pH value [51], [52]. Furthermore, many studies have shown that the induction of ROS production by various nanomaterials depends on the acidic environment of lysosomes in vivo [53], [54]. In order to investigate whether Ag-TiO2 SAN enhances SARS-CoV2 pseudovirus uptake by macrophages, a viral phagocytosis assay was performed. The mouse macrophage cell line RAW264.7 and the human macrophage cell line THP-1 were induced to M1 phase macrophages. As shown in Figure S16a, the adherent ability of M1 macrophages was increased. In addition, the markers of M1 macrophages were also upregulated compared with M0 macrophages (Figure S16b-c). In the phagocytosis assays, the concentration of SARS-CoV2 pseudovirus in the culture supernatant of mouse and human macrophages was significantly decreased in Ag-TiO2 SAN treated group than PBS control (Fig. 7e-f), indicating that Ag-TiO2 SAN promotes SARS-CoV2 pseudovirus uptake of macrophages and subsequent degradation. Finally, in order to understand the mechanisms underlying the anti-SARS-CoV2 effects of Ag-TiO2 SAN in vivo, we tracked the intracellular localization of Ag-TiO2 SAN by transmission electron microscope (TEM). Fig. 7g-h shows that Ag-TiO2 SAN colocalized with lysosomes of mouse and human macrophages. More importantly, flow cytometry analysis showed that Ag-TiO2 SAN significantly increased ROS generation in macrophages (Fig. 7i-j), and this result was confirmed by immunofluorescence assay (Figure S17). Thus, Ag-TiO2 SAN initially promotes virus uptake by macrophages. Under acid condition of lysosomes of macrophages, the SAN subsequently induces high level of ROS to degrade virus.
According to our results and other studies [51], [55], macrophages possess a higher tolerance to ROS than other cells. In this antiviral system, Ag-TiO2 SAN efficiently eliminated SARS-CoV2 pseudovirus in lysosomes of macrophages. However, this effect did not affect the viability of macrophages. The pseudovirus was degraded by the SAN depending on its intrinsic peroxidase-like activity in lysosomes of macrophages. However, the concentration of Ag-TiO2 SAN converts free radicals is not enough to kill host cells. Cellular viability is also not affected by other nanomaterials with peroxidase-like activity at appropriate concentrations [56], [57].
Conclusion
In this study, we designed a TiO2 supported single atom nanozyme containing 1 wt% atomically dispersed silver atoms (Ag-TiO2 SAN), which could serve as a highly efficient anti-SARS-CoV2 nanomaterial. First, Ag-TiO2 SAN displays a high adsorption ability for S1 protein of SARS-CoV2. The pull-down assay suggested that Ag-TiO2 SAN significantly inhibits the interaction between S1 RBD and its receptor hACE2. By theoretical calculation, we found the interaction between Ag atoms and asparagine and cysteine of S1 RBD. This combination of Ag atoms and amino acids explains the mechanism of high adsorption of SARS-CoV2 pseudovirus by the SAN and inhibition of S1 RBD binding to hACE2. Meanwhile, this nanomaterial exhibits limited toxicity due to its TiO2 carrier and low Ag atom load, suggesting Ag-TiO2 SAN can be applied in vivo as a nanozyme-based biosafety material. Second, we found that Ag-TiO2 SAN possesses peroxidase-like activity, producing high level of ROS under acid condition. Third, Ag-TiO2 SAN enhanced phagocytosis of SARS-CoV2 pseudovirus in macrophages and colocalized with lysosomes, including the production of high levels of ROS due to its peroxidase-like activity. As a result, SARS-CoV2 pseudovirus is broken down. Finally, with viral elimination models, Ag-TiO2 SAN efficiently eliminated SARS-CoV2 pseudovirus and spike protein. In summary, we successfully designed and achieved a gram-scale synthesis of a novel SAN for resisting and clearing SARS-CoV2 via its high adsorption and peroxidase-like activity.
Statistical Analysis
Results are expressed as the mean±SD of at least three independent experiments unless otherwise stated. Data were analyzed with GraphPad Prism 8 software (San Diego, CA). The unpaired two-sided student t-test was employed to determine the differences between two groups. *P < 0.05, **P < 0.01, ***P < 0.001.
CRediT authorship contribution statement
Daji Wang, Bin Zhang, Hui Ding: Designed and performed the experiments, Analyzed the data and wrote the original draft. Dan Liu, Jianquan Xiang, Zhongjun Li, Hongxia Duan, Jiyan Zheng, Zheng Liu, Bing Jiang, Yang Liu, Ni Xie, Han Zhang: Analyzed the data and provided valuable advice. Xuejiao J. Gao: Methodology, Formal analysis, Wrote original draft. Xuehui Chen: Protein structure analysis. Xiyun Yan, Kelong Fan, Guohui Nie: Conceptualization, Supervision.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
This work was supported by National Natural Science Foundation of China (81970875, 31530026, 31871005, 31900981, 82003303), Strategic Priority Research Program of CAS (XDB29040101), Key Research Program of Frontier Sciences, CAS (QYZDY-SSW-SMC013), Natural Science Foundation of Guangdong Province (2019A1515011495, 2018A030310665, 2020A151501787), Shenzhen Science and Technology Innovation Committee (JCYJ20170413162242627, ZDSYS201707281114196, JCYJ20190806163814395, JCYJ20180508152528735, JSGG20191129144225464, JCYJ20190806163805286, JCYJ20190809095811254, JCYJ20200109140412476), Sanming Project of Medicine in Shenzhen (SZSM201612031), Beijing Natural Science Foundation of China (7192123), Youth Innovation Promotion Association of Chinese Academy of Sciences (2018122, 2019093), China Postdoctoral Science Foundation Funded Project (2021M692217, 2019M660212), CAS Interdisciplinary Innovation Team (JCTD-2020-08). We thank Dr. Ruofei Zhang (Institute of Biophysics, Chinese Academy of Sciences) for his technical support. We thank Dr. Jiuyang He (Institute of Biophysics, Chinese Academy of Sciences) for language editing.
Footnotes
Supplementary data associated with this article can be found in the online version at doi:10.1016/j.nantod.2021.101243.
Appendix A. Supplementary material
.
References
- 1.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., Zhou H., Hu Z., Zhou W., Zhao L., Chen J., Meng Y., Wang J., Lin Y., Yuan J., Xie Z., Ma J., Liu W.J., Wang D., Xu W., Holmes E.C., Gao G.F., Wu G., Chen W., Shi W., Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wang L.-F., Anderson D.E. Viruses in bats and potential spillover to animals and humans. Curr. Opin. Virol. 2019;34:79–89. doi: 10.1016/j.coviro.2018.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ksiazek T.G., Erdman D.D., Goldsmith C.S., Zaki, Peret T.C.T., Emery S.L., Tong S., Urbani C., Comer J.A., Lim W. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. [DOI] [PubMed] [Google Scholar]
- 6.Mahase E. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020;368 doi: 10.1136/bmj.m641. [DOI] [PubMed] [Google Scholar]
- 7.Beyth N., Houri-Haddad Y., Domb A., Khan W., Hazan R. Alternative antimicrobial approach: nano-antimicrobial materials. Evid. -Based Complement. Altern. Med.: eCAM. 2015;2015 doi: 10.1155/2015/246012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Li L., Sun J., Li X., Zhang Y., Wang Z., Wang C., Dai J., Wang Q. Controllable synthesis of monodispersed silver nanoparticles as standards for quantitative assessment of their cytotoxicity. Biomaterials. 2012;33:1714–1721. doi: 10.1016/j.biomaterials.2011.11.030. [DOI] [PubMed] [Google Scholar]
- 9.Yu Y., Bu F., Zhou H., Wang Y., Cui J., Wang X., Nie G., Xiao H.H. Effect of titanium on microstructure, texture, and mechanical property of As-extruded Mg—Sn alloy. Front. Mater. 2020;7:2428–2434. [Google Scholar]
- 10.Zhu X., Radovic-Moreno A.F., Wu J., Langer R., Shi J. Nanomedicine in the management of microbial infection - overview and perspectives. Nano Today. 2014;9:478–498. doi: 10.1016/j.nantod.2014.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bonam S.R., Kotla N.G., Bohara R.A., Rochev Y., Webster T.J., Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today. 2021;36 doi: 10.1016/j.nantod.2020.101051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tripathi K.M., Ahn H.T., Chung M., Le X.A., Saini D., Bhati A., Sonkar S.K., Kim M.I., Kim T. N, S, and P-co-doped carbon quantum dots: intrinsic peroxidase activity in a wide pH range and its antibacterial applications. ACS Biomater. Sci. Eng. 2020;6:5527–5537. doi: 10.1021/acsbiomaterials.0c00831. [DOI] [PubMed] [Google Scholar]
- 13.Qin M., Cao Z., Wen J., Yu Q., Liu C., Wang F., Zhang J., Yang F., Li Y., Fishbein G., Yan S., Xu B., Hou Y., Ning Z., Nie K., Jiang N., Liu Z., Wu J., Yu Y., Li H., Zheng H., Li J., Jin W., Pang S., Wang S., Chen J., Gan Z., He Z., Lu Y. An antioxidant enzyme therapeutic for COVID‐19. Adv. Mater. 2020;32 doi: 10.1002/adma.202004901. [DOI] [PubMed] [Google Scholar]
- 14.Jiang D., Ni D., Rosenkrans Z.T., Huang P., Yan X., Cai W. Nanozyme: new horizons for responsive biomedical applications. Chem. Soc. Rev. 2019;48:3683–3704. doi: 10.1039/c8cs00718g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dubois L.H., Zegarski B.R., Nuzzo R.G. Fundamental studies of microscopic wetting on organic surfaces. 2. Interaction of secondary adsorbates with chemically textured organic monolayers. J. Am. Chem. Soc. 1990;112:570–579. [Google Scholar]
- 16.Oren E.E., Tamerler C., Sahin D., Hnilova M., Seker U.O.S., Sarikaya M., Samudrala R. A novel knowledge-based approach to design inorganic-binding peptides. Bioinformatics. 2007;23:2816–2822. doi: 10.1093/bioinformatics/btm436. [DOI] [PubMed] [Google Scholar]
- 17.Elechiguerra J.L., Burt J.L., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., Yacaman M.J. J. Nanobiotechnol. 2005;3:6. doi: 10.1186/1477-3155-3-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gao L., Zhuang J., Nie L., Zhang J., Zhang Y., Gu N., Wang T., Feng J., Yang D., Perrett S., Yan X. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat. Nanotechnol. 2007;2:577–583. doi: 10.1038/nnano.2007.260. [DOI] [PubMed] [Google Scholar]
- 19.Han L., Li C., Zhang T., Lang Q., Liu A. Au@Ag heterogeneous nanorods as nanozyme interfaces with peroxidase-like activity and their application for one-pot analysis of glucose at nearly neutral pH. ACS Appl. Mater. Interfaces. 2015;7:14463–14470. doi: 10.1021/acsami.5b03591. [DOI] [PubMed] [Google Scholar]
- 20.Gao F., He G., Yin H., Chen J., Liu Y., Lan C., Zhang S., Yang B. Titania-coated 2D gold nanoplates as nanoagents for synergistic photothermal/sonodynamic therapy in the second near-infrared window. Nanoscale. 2019;11:2374–2384. doi: 10.1039/c8nr07188h. [DOI] [PubMed] [Google Scholar]
- 21.Liang Q., Xi J., Gao X.J., Zhang R., Yang Y., Gao X., Yan X., Gao L., Fan K. A metal-free nanozyme-activated prodrug strategy for targeted tumor catalytic therapy. Nano Today. 2020;35 [Google Scholar]
- 22.Panáček A., Kvítek L., Smékalová M., Večeřová R., Kolář M., Röderová M., Dyčka F., Šebela M., Prucek R., Tomanec O., Zbořil R. Bacterial resistance to silver nanoparticles and how to overcome it. Nat. Nanotechnol. 2018;13:65–71. doi: 10.1038/s41565-017-0013-y. [DOI] [PubMed] [Google Scholar]
- 23.Dibrov P., Dzioba J., Gosink K.K., Häse C.C. Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae. Antimicrob. Agents Chemother. 2002;46:2668–2670. doi: 10.1128/AAC.46.8.2668-2670.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li Y., Lin Z., Zhao M., Xu T., Wang C., Hua L., Wang H., Xia H., Zhu B. Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways. ACS Appl. Mater. Interfaces. 2016;8:24385–24393. doi: 10.1021/acsami.6b06613. [DOI] [PubMed] [Google Scholar]
- 25.Zheng K., Setyawati M.I., Lim T.P., Leong D.T., Xie J. Antimicrobial cluster bombs: silver nanoclusters packed with daptomycin. ACS Nano. 2016;10:7934–7942. doi: 10.1021/acsnano.6b03862. [DOI] [PubMed] [Google Scholar]
- 26.Khan S.U., Al-Shahry M., Ingler W.B., Jr. Efficient photochemical water splitting by a chemically modified n-TiO2. Science. 2002;297:2243–2245. doi: 10.1126/science.1075035. [DOI] [PubMed] [Google Scholar]
- 27.Rasheed T., Adeel M., Nabeel F., Bilal M., Iqbal H.M.N. TiO2/SiO2 decorated carbon nanostructured materials as a multifunctional platform for emerging pollutants removal. Sci. Total Environ. 2019;688:299–311. doi: 10.1016/j.scitotenv.2019.06.200. [DOI] [PubMed] [Google Scholar]
- 28.Choi S.Y., Cho B. Extermination of influenza virus H1N1 by a new visible-light-induced photocatalyst under fluorescent light. Virus Res. 2018;248:71–73. doi: 10.1016/j.virusres.2018.02.011. [DOI] [PubMed] [Google Scholar]
- 29.Ma S., Zhan S., Jia Y., Zhou Q. Superior antibacterial activity of Fe3O4-TiO2 nanosheets under solar light. ACS Appl. Mater. Interfaces. 2015;7:21875–21883. doi: 10.1021/acsami.5b06264. [DOI] [PubMed] [Google Scholar]
- 30.Meng J., Zhang P., Zhang F., Liu H., Fan J., Liu X., Yang G., Jiang L., Wang S. A self-cleaning TiO2 nanosisal-like coating toward disposing nanobiochips of cancer detection. ACS Nano. 2015;9:9284–9291. doi: 10.1021/acsnano.5b04230. [DOI] [PubMed] [Google Scholar]
- 31.Huang L., Chen J., Gan L., Wang J., Dong S. Single-molecule detection of biomarker and localized cellular photothermal therapy using an optical microfiber with nanointerface. Sci. Adv. 2019;5:eaax4659. doi: 10.1126/sciadv.aax4659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhao S., Chen G., Zhou G., Yin L.C., Veder J.P., Johannessen B., Saunders M., Yang S.Z., De Marco R., Liu C. A universal seeding strategy to synthesize single atom catalysts on 2D materials for electrocatalytic applications. Adv. Funct. Mater. 2020;30 [Google Scholar]
- 33.Kim M.S., Lee J., Kim H.S., Cho A., Shim K.H., Le T.N., An S.S.A., Han J.W., Kim M.I., Lee J. Heme cofactor‐resembling Fe–N single site embedded graphene as nanozymes to selectively detect H2O2 with high sensitivity. Adv. Funct. Mater. 2020;30 [Google Scholar]
- 34.Zhang W., Zheng W. Single atom excels as the smallest functional material. Adv. Funct. Mater. 2016;26:2988–2993. [Google Scholar]
- 35.Zhang B., Asakura H., Zhang J., Zhang J., De S., Yan N. Stabilizing a platinum1single-atom catalyst on supported phosphomolybdic acid without compromising hydrogenation activity. Angew. Chem. 2016;128:8459–8463. doi: 10.1002/anie.201602801. [DOI] [PubMed] [Google Scholar]
- 36.Zhang B., Fan T., Xie N., Nie G., Zhang H. Versatile applications of metal single-atom @ 2D material nanoplatforms. Adv. Sci. (Weinh., Baden. -Wurtt., Ger. ) 2019;6 doi: 10.1002/advs.201901787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Xiang H., Feng W., Chen Y. Single-atom catalysts in catalytic biomedicine. Adv. Mater. 2020;32 doi: 10.1002/adma.201905994. [DOI] [PubMed] [Google Scholar]
- 38.Xu B., Wang H., Wang W., Gao L., Li S., Pan X., Wang H., Yang H., Meng X., Wu Q., Zheng L., Chen S., Shi X., Fan K., Yan X., Liu H. A single-atom nanozyme for wound disinfection applications. Angew. Chem. Int Ed. Engl. 2019;58:4911–4916. doi: 10.1002/anie.201813994. [DOI] [PubMed] [Google Scholar]
- 39.Huang L., Chen J., Gan L., Wang J., Dong S. Single-atom nanozymes. Sci. Adv. 2019;5 doi: 10.1126/sciadv.aav5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Xia S., Liu M., Wang C., Xu W., Lan Q., Feng S., Qi F., Bao L., Du L., Liu S., Qin C., Sun F., Shi Z., Zhu Y., Jiang S., Lu L. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30:343–355. doi: 10.1038/s41422-020-0305-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Muller M.A., Drosten C., Pohlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280. doi: 10.1016/j.cell.2020.02.052. e278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Liao S., Zhang Y., Pan X., Zhu F., Jiang C., Liu Q., Cheng Z., Dai G., Wu G., Wang L., Chen L. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Int J. Nanomed. 2019;14:1469–1487. doi: 10.2147/IJN.S191340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Soenen S.J., Rivera-Gil P., Montenegro J.M., Parak W.J., Smedt S.C.D., Braeckmans K. Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today. 2011;6:446–465. [Google Scholar]
- 44.Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009;8:543–557. doi: 10.1038/nmat2442. [DOI] [PubMed] [Google Scholar]
- 45.Siddiqi K.S., Husen A., Rao R.A.K. A review on biosynthesis of silver nanoparticles and their biocidal properties. J. Nanobiotechnol. 2018;16:14. doi: 10.1186/s12951-018-0334-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Elechiguerra J.L., Burt J.L., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., Yacaman M.J. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 2005;3:6. doi: 10.1186/1477-3155-3-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Chung Y.C., Chen I.H., Chen C.J. The surface modification of silver nanoparticles by phosphoryl disulfides for improved biocompatibility and intracellular uptake. Biomaterials. 2008;29:1807–1816. doi: 10.1016/j.biomaterials.2007.12.032. [DOI] [PubMed] [Google Scholar]
- 48.Hussain A.S., McKee M.L., Heinzel J.M., Sun X., Tatarchuk B.J. Density functional theory study of organosulfur selective adsorption on Ag–TiO2 adsorbents. J. Phys. Chem. C. 2014;118:14938–14947. [Google Scholar]
- 49.M. Wadman, J. Couzin-Frankel, J. Kaiser, C. Matacic. [DOI] [PubMed]
- 50.Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011;11:723–737. doi: 10.1038/nri3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445–455. doi: 10.1038/nature12034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lavin Y., Mortha A., Rahman A., Merad M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 2015;15:731–744. doi: 10.1038/nri3920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Liu L., Wei Y., Zhai S., Chen Q., Xing D. Dihydroartemisinin and transferrin dual-dressed nano-graphene oxide for a pH-triggered chemotherapy. Biomaterials. 2015;62:35–46. doi: 10.1016/j.biomaterials.2015.05.036. [DOI] [PubMed] [Google Scholar]
- 54.Yin C., Zhu H., Xie C., Zhang L., Chen P., Fan Q., Huang W., Pu K. Organic nanoprobe cocktails for multilocal and multicolor fluorescence imaging of reactive oxygen species. Adv. Funct. Mater. 2017;27 [Google Scholar]
- 55.Patella B., Buscetta M., Di Vincenzo S., Ferraro M., Aiello G., Sunseri C., Pace E., Inguanta R., Cipollina C. Electrochemical sensor based on rGO/Au nanoparticles for monitoring H2O2 released by human macrophages. Sens. Actuators B: Chem. 2021;327 [Google Scholar]
- 56.Yim G., Kim C.Y., Kang S., Min D.-H., Kang K., Jang H. Intrinsic peroxidase-mimicking Ir nanoplates for nanozymatic anticancer and antibacterial treatment. ACS Appl. Mater. Interfaces. 2020;12:41062–41070. doi: 10.1021/acsami.0c10981. [DOI] [PubMed] [Google Scholar]
- 57.Hu W.C., Younis M.R., Zhou Y., Wang C., Xia X.H. In situ fabrication of ultrasmall gold nanoparticles/2D MOFs hybrid as nanozyme for antibacterial therapy. Small. 2020;16 doi: 10.1002/smll.202000553. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.